With about ten started companies and fifty investments, Krim Talia has a good eye for the industry. Since June, he has been CEO of the accelerator and incubator Sting. In this interview, he shares his thoughts on the future of life science startups, Hagastaden, and what it takes to get more people to invest in their innovation.
